4//SEC Filing
Garland J. Scott 4
Accession 0001533228-26-000002
CIK 0001672619other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 6:10 PM ET
Size
5.5 KB
Accession
0001533228-26-000002
Insider Transaction Report
Form 4
Garland J. Scott
Director
Transactions
- Award
Stock Option (right to buy)
2026-01-07+59,372→ 59,372 totalExercise: $15.47Exp: 2036-01-07→ Common Stock (59,372 underlying)
Footnotes (1)
- [F1]1/36th of the shares subject to the option will vest on February 7, 2026 and each month thereafter, subject to the Reporting Person continuing as an outside director through each such date.
Documents
Issuer
Enliven Therapeutics, Inc.
CIK 0001672619
Entity typeother
Related Parties
1- filerCIK 0001533228
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 6:10 PM ET
- Size
- 5.5 KB